Pharmafile Logo
Pharmafocus logo
Advanced Search

Ondibta

Showing 1 posts of 1 posts found.

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026
Research and Development Diabetes, Ondibta, Sandoz

Sandoz has announced that its Ondibta (insulin glargine) has received approval from the European Commission (EC) for the treatment of …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026